Pharmaceuticals, Biotechnology and Life Sciences
Industry leaders, patient advocates, researchers unite to maximize the incredible potential of transformative gene therapies WASHINGTON–(BUSINESS WIRE)–The Institute for Gene…
DUBLIN–(BUSINESS WIRE)–The “Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), by Technology (Gene Synthesis, Bioinformatics), by Application (Tissue Regeneration,…
– Breakthrough Therapy Designation Based on Initial Results from Phase 1b/2 EV-103 Clinical Trial – BOTHELL, Wash. & TOKYO–(BUSINESS WIRE)–Seattle…
PALO ALTO, Calif.–(BUSINESS WIRE)–#SCOPE2020—Medable Inc., the leading software provider for decentralized clinical trials, today announced the launch of its Patient…
DUBLIN–(BUSINESS WIRE)–The “Global In-Silico Drug Discovery Market: Focus on Products, Technologies, Workflow, End Users, Country Data (17 Countries), and Competitive…
Presentation and webcast to take place at 9:00 a.m. ET on February 26 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Axcella (Nasdaq: AXLA), a clinical-stage…
Industry veteran to helm newly created position as H3 advances oncology pipeline CAMBRIDGE, Mass.–(BUSINESS WIRE)–H3 Biomedicine, Inc. (H3), a U.S.-based…
BERKELEY, Calif. & RICHMOND, Calif.–(BUSINESS WIRE)–Caribou Biosciences, Inc., a leading CRISPR genome editing company, and ProMab Biotechnologies, Inc., a biotechnology…
MINNEAPOLIS, Minn. & DURHAM, N.C.–(BUSINESS WIRE)–The CIBMTR® (Center for International Blood and Marrow Transplant Research®) today announced the selection of…
— Hillel Bachrach, Jason Camm and Zafrira Avnur join EnClear Therapies Board of Directors — — Investors include 20/20 HealthCare…